Endo Narcan

Shortages of naloxone are due to shutdown of DuPont sterile manufacturing facility, Endo explains (1"The Pink Sheet" March 19, p. 16). DuPont says manufacturing facility was closed for routine repair and maintenance. Endo expects production to be resumed by the end of March. DuPont's Manati, Puerto Rico facility received a warning letter in June 2000 for deviations from good manufacturing practices

Shortages of naloxone are due to shutdown of DuPont sterile manufacturing facility, Endo explains (¹ (Also see "Abbott Doubles Fentanyl Production To Address Hospital Shortages" - Pink Sheet, 19 Mar, 2001.)). DuPont says manufacturing facility was closed for routine repair and maintenance. Endo expects production to be resumed by the end of March. DuPont's Manati, Puerto Rico facility received a warning letter in June 2000 for deviations from good manufacturing practices.